Krystal Biotech Inc. (4KB)
XSTU
Real-time Data
06:00 AM
Day's Range
288.2052 wk Range
116.55Overview - 4KB - Krystal Biotech Inc.
Key Statistics
Valuation
Enterprise Value
6.68B
P/E (Trailing)
‪42.50‬
PEG Ratio
‪1.08‬
Price / Sales (TTM)
‪19.50‬
Price / Book
‪7.38‬
EV / EBITDA
‪39.16‬
Profitability
Gross Margin
‪94.60%‬
Profit Margin
‪54.81%‬
Operating Margin
‪48.99%‬
Return on Assets
‪9.36%‬
Return on Equity
‪20.12%‬
Ownership
Shares Outstanding
29.59M
Float
23.56M
Held by Insiders
‪10.82%‬
Held by Institutions
‪102.52%‬
Price stats
Beta
‪0.53‬
50-Day Avg
‪301.82‬
200-Day Avg
‪245.00‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 4KB - Krystal Biotech Inc.
Peers - 4KB - Krystal Biotech Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
Profile Summary - 4KB - Krystal Biotech Inc.
About
Krystal Biotech Inc. is a biotechnology company primarily focused on developing and commercializing gene therapy products for patients with rare dermatological conditions. Its innovative platform harnesses gene delivery technology to address unmet medical needs by developing a pipeline of products aimed at treating…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
